Looks eerily similar to INO a month or so ago. Expected indecision as we are setting up for P2 Trial results, late Apr early May per CC. As a Flag add ~2 to 3.56 and we get a target at +5.50, watch for test & hold of upper and lower Tri, then breakout and/or breakdown with back tests. Will be interesting to see how ATHX holds up depending on how the Biosector acts this week, as well the during the World Cancer Conf.